Tuesday, September 16, 2014

Introduction to Kyani Corporation

Hello everyone.

Today I will shock most of you.  But before I share my exciting news, I want to assure everyone that I have not abandoned my last 3 decades of work with L-arginine and L-citrulline as progenitors of nitric oxide.  Everything we learned and proved by the use of thousands of patients all over the world remains.

Through the years we observed little challenges with patients here and there. We witnessed the common lower bowel problems by a significant portion of the population (in other words – diarrhea), we recorded the cases of herpes virus activation including shingles and the ineffectiveness of lower doses where patients had compromised vascular endotheliums and/or elevated levels of ADMA (Asymmetric Dimethyl Arginine).  We also noticed patients with low blood oxygen saturation levels struggle to respond at lower dosings.

All the above having been said, throughout the years, the results we obtained from L-arginine/L-citruline supplementation were greater than any drug in our arsenal.

Now to my big news… Anyone that has followed my career or viewed my webcasts are aware the 1998 Nobel Prize in Medicine or Physiology was awarded to 3 scientists on their work regarding Nitric Oxide.  But what very few people know is that there are two distinctly separate pathways through which mammals produce Nitric Oxide.  The pathway we are familiar with is the protein pathway which uses L-arginine and L-citruline.

Here’s the exciting news, the parallel pathway the botanically based Nitrate and Nitrite pathway is so independent of the protein pathway that it has none, zip, nada, of the challenges of the protein pathway.

Recently a groundbreaking multi-day symposium was held at the Nobel Forum, Karolinska Institute in Stockholm, Sweden.  This symposium was convened to discuss new advances in understanding the role of plant based nitrate and nitrite in biology, nutrition and therapeutics.  Among the topics discussed was how botanically originated nitrate and nitrite metabolism occurs in both blood vessels and tissues to form NO, representing an alternative to ‘classical’ L-arginine-NO synthase and NO signaling. In particular, in situations of hypoxia, when the oxygen-dependent NO synthases may become dysfunctional, nitrite reduction is instead greatly enhanced. This one major advantage will benefit millions of people.  Additionally, the vast array of health benefits associated with L-arginine and L-citruline supplementation were acknowledged as similarly being created by Nitrate and Nitrite supplementation.

This symposium and the rapidly accumulating research is pointing the way to the future.  Without hesitation, I can categorically state, my focus is now on the parallel pathway due to its advantages and absence of disadvantages.

I enthusiastically encourage you to do your own research as I have and I am certain you will come to the same conclusion.

Should you desire to try either of these products, you can contact my office or order them directly from my website – www.endocrinetherapeutics.kyani.net

For those of you that would like to partner with me professionally and help me get the word out regarding the next chapter in the history of Nitrici Oxide, you can partner with me by becoming a distributor or simply recommending the products.  To become a distributor you can sign yourself up at the same website: www.endocrinetherapeutics.kyani.net, call my office at (650) 566-9810 or email me at joe at drjoeweb dot com

Please join me at my first free seminar, “The Next Chapter in Nitric Oxide”, this Thursday, September 18th, 2014 at 7:00pm.  It will be at the Holiday Inn and Suites San Mateo, 330 North Bayshore Blvd., San Mateo, CA.

~Dr. Joe